Loading clinical trials...
Loading clinical trials...
The primary purpose of this study is to assess the efficacy, tolerability and safety of RX-10045 Ophthalmic Solution in patients with Dry Eye Disease.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
C.T. Development America, Inc.
NCT07412860 · Dry Eye Syndromes, Dry Eye Disease (DED)
NCT07295691 · Autologous Serum Eye Drops, Dry Eye Syndrome
NCT03135327 · Multiple Sclerosis, Dry Eye Syndromes, and more
NCT02585414 · Dry Eye Syndromes
NCT06848829 · Dry Eye Syndromes
Andover Eye Associates
Andover, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions